Corpus Intelligence IC Memo — SUTTER LAKESIDE HOSPITAL 2026-04-26 14:11 UTC
IC Memo — SUTTER LAKESIDE HOSPITAL
Investment Committee Memorandum | CA | 25 beds | Grade B | EBITDA uplift $7.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SUTTER LAKESIDE HOSPITAL

CCN 051329 | LAKE, CA | 25 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

SUTTER LAKESIDE HOSPITAL is a 25-bed suburban community hospital in LAKE, CA with $95.3M in net patient revenue and a -5.2% operating margin. The hospital serves a payer mix of 45.0% Medicare, 2.6% Medicaid, and 52.4% commercial.

Thesis: Turnaround. Our ML models identify $7.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.2% to 2.2% (+736bps).

Net Revenue HCRIS$95.3M
Current EBITDA COMPUTED$-4.9M
Operating Margin COMPUTED-5.2%
Occupancy HCRIS76.6%
Revenue / Bed COMPUTED$3.8M
Net-to-Gross HCRIS29.6%
Distress Probability ML38.4%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
71
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -5.2% places it below the state median. Among 71 size-comparable peers (12-50 beds), the median margin is -8.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 71 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SUTTER LAKESIDE HOSPITAL (Target)CA25$95.3M-5.2%
TAHOE FOREST HOSPITALCA25$264.3M13.0%
PORTERVILLE DEVELOPMENTAL CENTCA17$193.6M-6.0%
ADVENTIST HEALTH REEDLEYCA49$187.1M1.8%
SUTTER DAVIS HOSPITALCA48$176.9M12.5%
ADVENTIST HEALTH UKIAH VALLEYCA50$173.4M-39.9%
ADVENTIST HEALTH CLEARLAKECA25$159.9M-6.3%
ST ELIZABETH COMMUNITY HOSPTICA49$159.2M3.5%
RIDGECREST REGIONAL HOSPITALCA25$149.6M-14.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.0M+210bp18mo
Cost to Collect4.5%2.5%$1.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.2M+122bp9mo
Clean Claim Rate88.0%96.0%$61K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.0M
Cost to Collect
$1.9M
Denial Rate Reduction
$1.9M
A/R Days Reduction
$1.2M
Clean Claim Rate
$61K
Total EBITDA Uplift$7.0M
Current EBITDA$-4.9M
+ RCM Uplift+$7.0M
Pro Forma EBITDA$2.1M
Current Margin-5.2%
Pro Forma Margin2.2%
WC Released (1x)$3.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-7.6M$37.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-7.6M$39.0M0.00x-100.0%
Bull Case9.0x11.0x$-6.8M$59.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.8M$63.1M0.00x-100.0%
Bear Case11.0x10.0x$-8.3M$5.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-8.3M$2.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 71 hospitals with 12-50 beds
  • Same-state prioritization (n=72)
  • Comp margins: P25=-18.6% / P50=-8.3% / P75=1.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.